 Junyi Hu
Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 7 | 2021 | 351 | 1.060 |
Why?
| | Macrophage Activation | 2 | 2020 | 193 | 0.710 |
Why?
| | RNA, Long Noncoding | 2 | 2020 | 177 | 0.630 |
Why?
| | Diabetic Foot | 1 | 2020 | 25 | 0.620 |
Why?
| | Skin | 3 | 2020 | 754 | 0.600 |
Why?
| | MicroRNAs | 6 | 2021 | 700 | 0.480 |
Why?
| | Membrane Glycoproteins | 3 | 2025 | 496 | 0.390 |
Why?
| | Cerium | 3 | 2021 | 19 | 0.390 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2020 | 198 | 0.290 |
Why?
| | Receptors, Lipoprotein | 1 | 2026 | 16 | 0.240 |
Why?
| | Intestinal Absorption | 1 | 2026 | 103 | 0.230 |
Why?
| | Fibroblasts | 3 | 2020 | 1032 | 0.230 |
Why?
| | Nanoparticles | 2 | 2021 | 519 | 0.230 |
Why?
| | Diabetes Mellitus | 3 | 2021 | 1092 | 0.220 |
Why?
| | Dietary Fats | 1 | 2026 | 313 | 0.200 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2026 | 233 | 0.200 |
Why?
| | Neuroendocrine Tumors | 1 | 2025 | 112 | 0.200 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2025 | 154 | 0.200 |
Why?
| | Wounds and Injuries | 3 | 2016 | 952 | 0.190 |
Why?
| | Immunotherapy, Adoptive | 1 | 2025 | 337 | 0.170 |
Why?
| | Mice | 11 | 2026 | 18329 | 0.160 |
Why?
| | Macrophages | 2 | 2020 | 1510 | 0.160 |
Why?
| | Receptors, Leptin | 1 | 2020 | 25 | 0.160 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2017 | 59 | 0.160 |
Why?
| | RAW 264.7 Cells | 1 | 2020 | 50 | 0.150 |
Why?
| | STAT1 Transcription Factor | 1 | 2020 | 68 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2025 | 881 | 0.150 |
Why?
| | Dermis | 1 | 2019 | 32 | 0.150 |
Why?
| | Bleomycin | 1 | 2021 | 253 | 0.150 |
Why?
| | Disease Models, Animal | 5 | 2025 | 4556 | 0.150 |
Why?
| | Signal Transduction | 4 | 2020 | 5221 | 0.140 |
Why?
| | Lung Injury | 1 | 2021 | 237 | 0.140 |
Why?
| | Fetal Heart | 1 | 2019 | 57 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2021 | 302 | 0.140 |
Why?
| | Reactive Oxygen Species | 2 | 2020 | 621 | 0.140 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2019 | 177 | 0.130 |
Why?
| | Animals | 13 | 2026 | 38030 | 0.130 |
Why?
| | Drug Delivery Systems | 1 | 2021 | 379 | 0.130 |
Why?
| | Hyperglycemia | 2 | 2020 | 374 | 0.130 |
Why?
| | Pancreatic Neoplasms | 1 | 2025 | 918 | 0.130 |
Why?
| | Collagen | 1 | 2019 | 455 | 0.120 |
Why?
| | Neovascularization, Physiologic | 2 | 2015 | 194 | 0.120 |
Why?
| | Extracellular Matrix Proteins | 1 | 2017 | 157 | 0.120 |
Why?
| | Stem Cell Factor | 1 | 2015 | 17 | 0.110 |
Why?
| | Pregnancy, Animal | 1 | 2015 | 52 | 0.110 |
Why?
| | Fetus | 1 | 2019 | 803 | 0.110 |
Why?
| | Collagen Type III | 3 | 2019 | 18 | 0.100 |
Why?
| | Collagen Type I | 3 | 2019 | 147 | 0.090 |
Why?
| | Obesity | 1 | 2026 | 3057 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2025 | 2182 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1208 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 625 | 0.080 |
Why?
| | Liver | 1 | 2019 | 1884 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 905 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2870 | 0.070 |
Why?
| | NADPH Oxidase 2 | 2 | 2020 | 35 | 0.070 |
Why?
| | Mice, Inbred C57BL | 4 | 2026 | 5988 | 0.070 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2019 | 131 | 0.070 |
Why?
| | Chylomicrons | 1 | 2026 | 19 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2014 | 2829 | 0.060 |
Why?
| | Lipoproteins, HDL | 1 | 2026 | 89 | 0.060 |
Why?
| | Up-Regulation | 2 | 2020 | 851 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2017 | 341 | 0.060 |
Why?
| | Intestine, Small | 1 | 2026 | 166 | 0.050 |
Why?
| | Blotting, Western | 2 | 2017 | 1187 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 1 | 2025 | 236 | 0.050 |
Why?
| | Humans | 8 | 2026 | 144261 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 928 | 0.050 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 732 | 0.040 |
Why?
| | Female | 5 | 2020 | 77976 | 0.040 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2020 | 162 | 0.040 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2603 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 240 | 0.040 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2019 | 28 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2020 | 271 | 0.040 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2019 | 80 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2026 | 3119 | 0.040 |
Why?
| | Organ Specificity | 1 | 2019 | 312 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2020 | 395 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2020 | 379 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1519 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3539 | 0.030 |
Why?
| | Regeneration | 1 | 2019 | 196 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2017 | 246 | 0.030 |
Why?
| | Proteolysis | 1 | 2017 | 173 | 0.030 |
Why?
| | NADPH Oxidases | 1 | 2017 | 124 | 0.030 |
Why?
| | Sheep | 1 | 2019 | 880 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2020 | 780 | 0.030 |
Why?
| | Keratin-15 | 1 | 2015 | 17 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2020 | 1217 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2016 | 610 | 0.030 |
Why?
| | NF-kappa B | 1 | 2017 | 661 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2017 | 1172 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 981 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 240 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2015 | 901 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 297 | 0.020 |
Why?
| | Glucose | 1 | 2017 | 1046 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 557 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4146 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2879 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1715 | 0.020 |
Why?
| | Cell Movement | 1 | 2015 | 965 | 0.020 |
Why?
| | Gene Expression | 1 | 2014 | 1487 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2877 | 0.020 |
Why?
| | RNA | 1 | 2015 | 939 | 0.020 |
Why?
| | Lung | 1 | 2021 | 4108 | 0.020 |
Why?
| | Male | 2 | 2026 | 72035 | 0.010 |
Why?
| | Pregnancy | 1 | 2015 | 7180 | 0.010 |
Why?
| | Middle Aged | 1 | 2020 | 35762 | 0.010 |
Why?
|
|
Hu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|